Menu
Recruiting NCT05849025

A Study of Invasive Hemodynamic for MACHD Registry

Observational Healthy Congenital Heart Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Healthy, Congenital Heart Disease. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry

Overview

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Primary outcome measures

  • Pulmonary vascular reserve [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Capacity to Consent
  • BMI </= 30
  • Systolic BP </= 140mmHg
  • Diastolic BP </= 90
  • eGFR > 30 (within prior 3 months) to confirm kidney function
  • Able to undergo an MRI

Exclusion criteria

  • History of Cardiovascular disease that may affect the results of the testing performed.
  • Any Current orthopedic limitations
  • Currently taking any cardiac medication
  • Pregnancy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Mayo Clinic Rochester — Rochester

Identifiers

NCT: NCT05849025 · 23-001939 · R01HL160761

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗